May-April
Platelet Count (and fibrosis stage) Predicts
Sustained Viral Response (SVR) in the Re-Treatment of Previous
Interferon/Ribavirin (I/R) Non-Responders (NR): Results from the
EPIC3 Program
Peripheral blood serum markers for
apoptosis and liver fibrosis: Are they trustworthy indicators
Performance of Transient Elastography for the
Staging of Liver Fibrosis: A Meta-Analysis
-
Targeting siRNA to arrest fibrosis -
Alcohol, Tobacco, and Cannabis All May Promote
Liver Disease Progression in People with Chronic Hepatitis C
Pegylated Interferon plus Ribavirin for Patients with
HCV-related Liver Cirrhosis
FibroScan for Diagnosis of Fibrosis in Patients with
Acute Viral Hepatitis and Recurrent Hepatitis C
Liver Fibrosis Progression in HIV-HCV Coinfected
Patients Treated with Interferon plus Ribavirin
March-February
Insulin Resistance is a Risk Factor for Liver
Fibrosis Even without Steatosis
Computed tomography Predicts Fibrosis
Virological response to peg-monotherapy
improves fibrosis in Hep C
Influence of Cannabis Use on Severity
of Hepatitis C Disease
SVR and Disease Progression
January 2008
CT Scans for Monitoring Liver Fibrosis
Ribosomal S-6 Kinase Mediates Development of
Liver Fibrosis
Chronic Marijuana Use May Increase Fibrosis
for Hep C Patients
Interferon Maintenance Therapy
and Liver Disease Progression
Ursodiol Lowers Liver Enzymes in HCV Study
Researchers Show that Fibrosis can be Stopped, Cured
and Reversed
News Archives
2007
2006
2005-2003
|
